The ATHENA human papillomavirus study: Design, methods, and baseline results

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 1, 2012, Pages 46.e1-46.e11

  Wright Jr , Thomas C ^a   Stoler, Mark H ^b   Behrens, Catherine M ^c   Apple, Raymond ^c   Derion, Toniann ^c   Wright, Teresa L ^c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Addressing the Need for Advanced HPV Diagnostics study; cervical cancer screening; cervical intraepithelial neoplasia; genotype; human papillomavirus deoxyribonucleic acid testing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

EID: 84455199713     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.07.024     Document Type: Article

References (23)

1. R.J. Kurman, L.H. Ellenson, B.M. Ronnett Blaustein's pathology of the female genital tract 2002 Springer New York, NY
2. S.F. Altekruse, C.L. Kosary, M. Krapcho et al. SEER cancer statistics review, 1975-2007 2009 National Cancer Institute Bethesda, MD
3. American Cancer Society What are the key statistics about cervical cancer? http://www.cancer.org/Cancer/CervicalCancer/DetailedGuide/index Accessed March 13, 2010
4. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ J Low Genit Tract Dis 11 2007 223 239
5. S. de Sanjose, W.G. Quint, L. Alemany et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 2010 1048 1056
6. Cervista HPV HR test instructions for use 2009 Third Wave Technologies, Inc Madison, WI
7. hc2 High-Risk HPV DNA Test [package insert] 2007 Digene Corp Gaithersburg, MD
8. ALTS Group Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance Am J Obstet Gynecol 188 2003 1383 1392
9. M.H. Stoler, T.C. Wright Jr, A. Sharma, R. Apple, K. Gutekunst, T.L. Wright High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study Am J Clin Pathol 135 2011 468 475
10. X.H. Zhou, N.A. Obuchowski, D.M. Obuchowski Statistical methods in diagnostic medicine 2002 John Wiley and Sons New York, NY
11. M. Chernick Bootstrapping methods: a practitioner's guide 1998 Wiley Interscience New York 8 and 112
12. US Census Bureau Table 6 Resident population by sex, race, and hispanic-origin status: 2000 to 2009 http://www.census.gov/compendia/statab/ 2011/tables/11s0006.pdf Accessed March 3, 2011
13. G.M. Eversole, A.T. Moriarty, M.R. Schwartz et al. Practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology, 2006 Arch Pathol Lab Med 134 2010 331 335
14. P.E. Castle, B. Fetterman, N. Poitras, T. Lorey, R. Shaber, W. Kinney Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting Obstet Gynecol 113 2009 595 600
15. E.F. Dunne, E.R. Unger, M. Sternberg et al. Prevalence of HPV infection among females in the United States JAMA 297 2007 813 819
16. American Society for Colposcopy and Cervical Pathology HPV genotyping clinical update 2009 http://www.asccp.org/consensus.shtml Accessed April 29, 2009
17. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests Am J Obstet Gynecol 197 2007 346 355
18. S.L. Kulasingam, J.P. Hughes, N.B. Kiviat et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 2002 1749 1757
19. L. Denny, L. Kuhn, M. De Souza, A.E. Pollack, W. Dupree, T.C. Wright Jr Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial JAMA 294 2005 2173 2181
20. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588
21. P. Sasieni Estimating prevalence when the true disease status is incompletely ascertained Stat Med 20 2001 935 949
22. G.M. Clifford, R.K. Rana, S. Franceschi, J.S. Smith, G. Gough, J.M. Pimenta Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer Cancer Epidemiol Biomarkers Prev 14 2005 1157 1164
23. J.S. Smith, L. Lindsay, B. Hoots et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update Int J Cancer 121 2007 621 632